Pilot study on the value of echocardiography combined with lung ultrasound to evaluate COVID-19 pneumonia

Cardiovasc Ultrasound. 2022 Jan 19;20(1):2. doi: 10.1186/s12947-021-00271-0.

Abstract

Background: This study aimed to investigate the relationship between echocardiography results and lung ultrasound score (LUS) in coronavirus disease 2019 (COVID-19) pneumonia patients and evaluate the impact of the combined application of these techniques in the evaluation of COVID-19 pneumonia.

Methods: Hospitalized COVID-19 pneumonia patients who underwent daily lung ultrasound and echocardiography were included in this study. Patients with tricuspid regurgitation within three days of admission were enrolled. Moreover, the correlation and differences between their pulmonary artery pressure (PAP) and LUS on days 3, 8, and 13 were analyzed. The inner diameter of the pulmonary artery root as well as the size of the atria and ventricles were also considered.

Results: The PAP on days 3, 8, and 13 of hospitalization was positively correlated with the LUS (r = 0.448, p = 0.003; r = 0.738, p < 0.001; r = 0.325, p = 0.036, respectively). On day 8, the values of both PAP and LUS were higher than on days 3 and 13 (p < 0.01). Similarly, PAP and LUS were significantly increased in 92.9% (39/42) and 90.5% (38/42) of patients, respectively, and at least one of these two values was positive in 97.6% (41/42) of cases. The inner diameters of the right atrium, right ventricle, and pulmonary artery also differed significantly from their corresponding values on days 3 and 13 (p < 0.05).

Conclusions: PAP is positively correlated with LUS in COVID-19 pneumonia. The two values could be combined for a more precise assessment of disease progression and recovery status.

Keywords: COVID-19; Echocardiography; Lung ultrasound score; Pulmonary arterial pressure.

MeSH terms

  • COVID-19*
  • Echocardiography
  • Humans
  • Lung / diagnostic imaging
  • Pilot Projects
  • Pneumonia* / diagnostic imaging
  • SARS-CoV-2
  • Ultrasonography